Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects
- 1 July 2008
- Vol. 26 (34) , 4314-4319
- https://doi.org/10.1016/j.vaccine.2008.06.049
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Pretreatment with Cisplatin Enhances E7-Specific CD8+ T-Cell–Mediated Antitumor Immunity Induced by DNA VaccinationClinical Cancer Research, 2008
- DNA vaccines: precision tools for activating effective immunity against cancerNature Reviews Cancer, 2008
- Targeting death-inducing receptors in cancer therapyOncogene, 2007
- Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cellsExpert Review of Vaccines, 2007
- Epigallocatechin-3-Gallate Enhances CD8+ T Cell–Mediated Antitumor Immunity Induced by DNA VaccinationCancer Research, 2007
- Testicular germ cell sensitivity to TRAIL-induced apoptosis is dependent upon p53 expression and is synergistically enhanced by DR5 agonistic antibody treatmentApoptosis, 2006
- Comparison of HPV DNA vaccines employing intracellular targeting strategiesGene Therapy, 2004
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002
- Biological activities and molecular targets of the human papillomavirus E7 oncoproteinOncogene, 2001
- DNA vaccinesLife Sciences, 1996